Processa Pharmaceuticals Long Term Deferred Charges (Quarterly) Analysis

Processa Pharmaceuticals, Inc. (PCSA)

2.10 -0.18 (-7.89%) USD | NASDAQ | Feb 20, 16:00

2.00 -0.10 (-4.76%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for PCSA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Kodiak Sciences, Inc.	--
Pyxis Oncology, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--